A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
A computer model suggests an omega-3 phospholipid (EPA-PC) can form a stable but unproven interaction with the GCase enzyme linked to Gaucher disease.
Salmon and krill phospholipids differ in EPA/DHA ratios and liposome particle size, but both show promise as stable carriers for omega-3 delivery systems.
Fish oil plus L-carnitine in hen feed improved egg production and increased omega-3 fatty acid content in egg yolks.
Adding 5% orange peel extract to algae cultures increased EPA content from 6.4% to 9.8%, showing citrus waste can enhance omega-3 production during algae cultivation.
In a mouse colitis model, krill oil reduced inflammation and reshaped gut bacteria and metabolite patterns linked to gut lining health.
In mice, combining tart cherry and fish oil more strongly improved gut bacteria balance and intestinal barrier gene expression in females than males after a high-fat diet.
In lab tests, EPA—but not DHA—protected dog intestinal cells from oxidative damage, inflammation, and premature aging.
Across 20 trials, omega-3 more consistently reduced arterial stiffness at higher doses (1.8-4g/day) taken for 12+ weeks, especially in higher-risk populations.
A narrative review finds omega-3, vitamin D3, and vitamin K2 share biological pathways linking heart, brain, and bone aging, but no trial has proven the combination beats individual nutrients or placebo.